Uncovering the trimethylamine-producing bacteria of the human gut microbiota

BackgroundTrimethylamine (TMA), produced by the gut microbiota from dietary quaternary amines (mainly choline and carnitine), is associated with atherosclerosis and severe cardiovascular disease. Currently, little information on the composition of TMA producers in the gut is available due to their low abundance and the requirement of specific functional-based detection methods as many taxa show disparate abilities to produce that compound.ResultsIn order to examine the TMA-forming potential of microbial communities, we established databases for the key genes of the main TMA-synthesis pathways, encoding choline TMA-lyase (cutC) and carnitine oxygenase (cntA), using a multi-level screening approach on 67,134 genomes revealing 1107 and 6738 candidates to exhibit cutC and cntA, respectively. Gene-targeted assays enumerating the TMA-producing community by quantitative PCR and characterizing its composition via Illumina sequencing were developed and applied on human fecal samples (n = 50) where all samples contained potential TMA producers (cutC was detected in all individuals, whereas only 26% harbored cntA) constituting, however, only a minor part of the total community (below 1% in most samples). Obtained cutC amplicons were associated with various taxa, in particular with Clostridium XIVa strains and Eubacterium sp. strain AB3007, though a bulk of sequences displayed low nucleotide identities to references (average 86% ± 7%) indicating that key human TMA producers are yet to be isolated. Co-occurrence analysis revealed specific groups governing the community structure of cutC-exhibiting taxa across samples. CntA amplicons displayed high identities (~99%) to Gammaproteobacteria-derived references, primarily from Escherichia coli. Metagenomic analysis of samples provided by the Human Microbiome Project (n = 154) confirmed the abundance patterns as well as overall taxonomic compositions obtained with our assays, though at much lower resolution, whereas 16S ribosomal RNA gene sequence analysis could not adequately uncover the TMA-producing potential.ConclusionsIn this study, we developed a diagnostic framework that enabled the quantification and comprehensive characterization of the TMA-producing potential in human fecal samples. The key players were identified, and together with predictions on their environmental niches using functional genomics on most closely related reference strains, we provide crucial information for the development of specific treatment strategies to restrain TMA producers and limit their proliferation.

[1]  T. Karlsen,et al.  Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure Running head : Microbiota and heart failure , 2014 .

[2]  Katherine H. Huang,et al.  A framework for human microbiome research , 2012, Nature.

[3]  Paramvir S. Dehal,et al.  FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.

[4]  Jordan A. Fish,et al.  Ecological Patterns of nifH Genes in Four Terrestrial Climatic Zones Explored with Targeted Metagenomics Using FrameBot, a New Informatics Tool , 2013, mBio.

[5]  Jeroen Raes,et al.  Microbiology Meets Big Data: The Case of Gut Microbiota-Derived Trimethylamine. , 2015, Annual review of microbiology.

[6]  Brian J. Bennett,et al.  Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease , 2011, Nature.

[7]  F. Bushman,et al.  Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis , 2013, Nature Medicine.

[8]  P. Turnbaugh,et al.  Characterization and Detection of a Widely Distributed Gene Cluster That Predicts Anaerobic Choline Utilization by Human Gut Bacteria , 2015, mBio.

[9]  J. Christodoulou.  Trimethylaminuria: An under‐recognised and socially debilitating metabolic disorder , 2012, Journal of paediatrics and child health.

[10]  A. Uitterlinden,et al.  Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA , 1993, Applied and environmental microbiology.

[11]  E. Balskus,et al.  Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme , 2012, Proceedings of the National Academy of Sciences.

[12]  J. Tiedje,et al.  Microbial Community Analysis with Ribosomal Gene Fragments from Shotgun Metagenomes , 2015, Applied and Environmental Microbiology.

[13]  Rodrigo Lopez,et al.  Analysis Tool Web Services from the EMBL-EBI , 2013, Nucleic Acids Res..

[14]  Jordan A. Fish,et al.  Xander: employing a novel method for efficient gene-targeted metagenomic assembly , 2015, Microbiome.

[15]  Xin Chen,et al.  dbCAN: a web resource for automated carbohydrate-active enzyme annotation , 2012, Nucleic Acids Res..

[16]  J. Spertus,et al.  Serum Trimethylamine-N-Oxide is Elevated in CKD and Correlates with Coronary Atherosclerosis Burden. , 2016, Journal of the American Society of Nephrology : JASN.

[17]  A. Howe,et al.  Ecology, Evolution and Organismal Biology Publications Ecology, Evolution and Organismal Biology Demonstrating Microbial Co-occurrence Pattern Analyses within and between Ecosystems Demonstrating Microbial Co-occurrence Pattern Analyses within and between Ecosystems , 2022 .

[18]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[19]  S. Hazen,et al.  γ-Butyrobetaine is a proatherogenic intermediate in gut microbial metabolism of L-carnitine to TMAO. , 2014, Cell metabolism.

[20]  Fredrik H. Karlsson,et al.  Symptomatic atherosclerosis is associated with an altered gut metagenome , 2012, Nature Communications.

[21]  Brandi L. Cantarel,et al.  Complex Carbohydrate Utilization by the Healthy Human Microbiome , 2012, PloS one.

[22]  Karen P. Scott,et al.  16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice , 2015, Microbiome.

[23]  J. Tiedje,et al.  Naïve Bayesian Classifier for Rapid Assignment of rRNA Sequences into the New Bacterial Taxonomy , 2007, Applied and Environmental Microbiology.

[24]  Zeneng Wang,et al.  Intestinal Microbial Metabolism of Phosphatidylcholine and Cardiovascular Risk , 2013 .

[25]  Peer Bork,et al.  Enterotypes of the human gut microbiome , 2011, Nature.

[26]  K. Rajakumar,et al.  Carnitine metabolism to trimethylamine by an unusual Rieske-type oxygenase from human microbiota , 2014, Proceedings of the National Academy of Sciences.

[27]  K. Strissel,et al.  Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice , 2014, The ISME Journal.

[28]  F. Rey,et al.  Intestinal Microbiota Composition Modulates Choline Bioavailability from Diet and Accumulation of the Proatherogenic Metabolite Trimethylamine-N-Oxide , 2015, mBio.

[29]  James R. Cole,et al.  Ribosomal Database Project: data and tools for high throughput rRNA analysis , 2013, Nucleic Acids Res..

[30]  J. Tiedje,et al.  Diet is a major factor governing the fecal butyrate-producing community structure across Mammalia, Aves and Reptilia , 2014, The ISME Journal.

[31]  Peter Williams,et al.  IMG: the integrated microbial genomes database and comparative analysis system , 2011, Nucleic Acids Res..

[32]  J. Tiedje,et al.  Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data , 2014, mBio.